[HTML][HTML] [18F] FDG-PET/CT radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications

R Manafi-Farid, E Askari, I Shiri, C Pirich… - Seminars in nuclear …, 2022 - Elsevier
Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors

M Guberina, N Guberina, C Pöttgen, T Gauler… - …, 2022 - Future Medicine
The pivotal PACIFIC trial defined durvalumab consolidation as the new standard of care in
patients with stage III non-small-cell lung cancer treated with definitive radiochemotherapy …

[HTML][HTML] Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice

M Guberina, A Santiago, C Pöttgen… - Clinical and …, 2023 - Elsevier
Background and purpose Definitive radiochemotherapy (RCT) for non-small cell lung cancer
(NSCLC) in UICC/TNM I–IVA (singular, oligometastatic) is one of the treatment methods with …

[HTML][HTML] [68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas

N Guberina, L Kessler, C Pöttgen, M Guberina… - Scientific Reports, 2022 - nature.com
Abstract Biliary-tract-carcinomas (BTC), pancreatic-ductal-adenocarcinomas (PDAC) and
adenoidcystic-carcinomas (AC) have in common that they are traditionally treated with large …

[HTML][HTML] Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer

X Chen, G Bai, R Zang, P Song, F Bie, Q Huai, Y Li… - Translational …, 2023 - Elsevier
Purpose The aim of present study was to investigate the efficiency of 18 F-FDG uptake in
predicting major pathological response (MPR) in resectable non-small cell lung cancer …

[PDF][PDF] Reyhaneh Manafi-Farid, MD,* Emran Askari, MD, Isaac Shiri, PhD, z Christian Pirich, MD, PhD, x Mahboobeh Asadi, MSc,* Maziar Khateri, MSc,* Habib Zaidi …

M Beheshti - Semin Nucl Med - hug.ch
Lung cancer is the second most common cancer and the leading cause of cancer-related
death. 1 Despite the decrease in mortality in recent decades, 2 it remains a public health …

[PDF][PDF] Clinical and Translational Radiation Oncology

M Guberina, A Santiago, C Pöttgen, F Indenkämpen… - duepublico2.uni-due.de
Background and purpose: Definitive radiochemotherapy (RCT) for non-small cell lung
cancer (NSCLC) in UICC/TNM I–IVA (singular, oligometastatic) is one of the treatment …